Download The Anti-Infectives Market Brochure

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Hospital-acquired infection wikipedia , lookup

Transcript
Brochure
More information from http://www.researchandmarkets.com/reports/2860574/
The Anti-Infectives Market
Description:
The need for new agents to fight drug-resistant bacteria is creating both challenges and significant market
opportunities
for pharmaceutical manufacturers and biotechnology companies. Divided into two primary market
segments, antibacterials and antifungals, this comprehensive Kalorama Information study offers in-depth
coverage of the $9 billion U.S. market for existing and emerging anti-infective drugs. Readers find detailed
market analysis, including historical, current and forecast market size, for each of the market segments. Upto-date information on products in development and their impact on the market are provided. Detailed
profiles of major competitors in each market segment are also included.
Contents:
Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
Trends Affecting the Market
Industry Structure and Leading Competitors
The End User
Introduction
The Microbiology of Infection
Causative Agents
Bacteria
Chlamydiae
Fungi
Mycoplasmas
Protozoa
Rickettsiae
Viruses
Helminths
Modes of Transmission
The Body's Defense against Infection
Antiseptics
Neutralization and Phagocytosis
Recognition of Pathogens
Immunity
Successful Pathogens
Existing and Emerging Infectious Diseases
Bacterial Infections
Bacterial Meningitis
Gastrointestinal Infections and Food Poisoning
Peptic Ulcer Disease
Legionnaires' Disease
Lyme Disease
Pneumonia
Plague
Sexually Transmitted Diseases
Tetanus
Tuberculosis
Upper Respiratory Infections
Otitis Media
Streptococcal Pharyngitis
Whooping Cough
Urinary Tract Infections
Fungal Infections
Aspergillosis
Blastomycosis
Candidiasis
Cryptococcosis
Histoplasmosis
Other Infectious Diseases
Acquired Immune Deficiency Syndrome
Malaria
Epidemiology
Demographics and Patient Populations
Compromised Immunity
Child Care Facilities
The Elderly
Nosocomial Infections
Resistance to Anti-Infective Drugs
Systemic Antibacterials
Product Classifications
Existing Systemic Antibacterials
Beta-Lactamase Inhibitors
Clavulanic Acid
Impenem
Sulbactam
Tazobactam
Products
Cephalosporins
First-Generation Cephalosporins
Second-Generation Cephamosporins
Third-Generation Cephalosporins
Fourth-Generation Cephalosporins
Macrolides and Macrolide Combinations
Azithromycin
Clarithromycin
Dirithromycin
Erythromycin
Troleandomycin
Penicillins
Natural Penicillins
Semisynthetic Penicillins
Quinolones
Tetracyclines
Other Antibacterial Therapies
Amebicides and Antimalarial Agents
Aminoglycosides
Antituberculosis Agents
Sulfonamides and Combinations
Other Miscellaneous
Research and Development
Products in Development
Macrolides
Quinolones
Other
Emerging Antibacterials
Biotechnology Trends
Delivery Channels
Market Size and Forecast
Beta-Lactamase Inhibitors Cephalosporins
Macrolides
Penicillins
Quinolones
Tetracyclines
Other Antibacterial Therapies
Emerging Antibacterial Therapies
Competitive Analysis
Beta-Lactamase Inhibitors
Cephalosporins
Macrolides
Penicillins
Quinolones
Tetracyclines
Market Analysis
Beta-Lactamase Inhibitors
Cephalosporins
Macrolides
Penicillins
Quinolones
Tetracyclines
Other Antibacterial Therapies
Emerging Antibacterial Therapies
Systemic Antifungals
Product Classifications
Existing Systemic Antifungals
Amphotericin B
Oral and Parenteral Formulations
Lipid and Liposomal Formulations
Azoles
Other Systemic Antifungal Therapies
Research and Development
Products in Development
Azoles
Emerging Antifungals
Biotechnology Trends
Delivery Channels
Market Size and Forecast
Competitive Analysis
Market Analysis
Issues and Trends
Cost Containment
Disease Management Issues
Drug-Resistant Infections
Emerging and Outbreak Infections
Generic Competition
Outpatient Therapy
Patient Population
Physicians' Prescribing Practices
Reimbursement Issues
Treatment Guidelines
Market Summary
Industry Structure
Major Industry Participants
Alliances and Collaborations
The U.S. Market for Anti-Infectives
Market Size and Forecast
Antibacterials
Antifungals
Competitor Profiles
Abbott Laboratories Inc.
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
American Home Products Corporation
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Bayer Corporation
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Bristol-Myers Squibb Company
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Eli Lilly and Company
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Glaxo Wellcome Inc.
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Hoechst Marion Roussel Inc
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Johnson & Johnson
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
The Liposome Company, Inc.
History and Lines of Business
Financial Information
Anti-Infective Therapies
Corporate Strategies
Analysis
Merck & Co. Inc
History Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Mylan Laboratories, Inc
History and Line of Business
Financial Information
Anti-Infective Therapies
Corporate Strategies
Analysis
Pfizer Inc.
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Roche Laboratories, Inc
History and Lines of Business
Financial Information
Anti-Infective Therapies Research and Development
Corporate Strategies
Analysis
SmithKline Beecham Corporation
History and Lines of Business
Financial Information
Anti-Infective Therapies
Research and Development
Corporate Strategies
Analysis
Appendix: Company Names and Addresses
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2860574/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct.
Product Name:
The Anti-Infectives Market
Web Address:
http://www.researchandmarkets.com/reports/2860574/
Office Code:
SCHL3FA7
Product Format
Please select the product format and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 2437
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World